查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1426873

全球兽医疼痛管理市场：~2030 年

Veterinary Pain Management Market Forecast to 2030
出版日期: | 出版商: Market Research Future | 英文 245 Pages | 订单完成后即时交付

价格

在预测期内，全球兽医疼痛管理市场规模预计将稳定维持在 6.44% 的复合年增长率。 动物疾病的流行、伴侣动物繁殖率的上升以及宠物数量的增加等因素正在推动市场的成长。

按地区划分，北美市场在 2022 年占据最大份额。 这是由于该地区宠物数量的增加和神经系统疾病的增加。 此外，欧洲市场是世界第二大市场，由于传染病的传播，人们对疼痛管理产品的兴趣日益浓厚。 亚太地区的成长得益于中国、印度和韩国等快速发展经济体的存在。 该地区为进入者提供了许多宝贵的发展机会。 宠物选择的扩大和伴侣动物数量的增加正在推动市场的发展。

本报告调查了全球动物疼痛管理市场，提供了市场的定义和概述，分析了市场成长的各种影响因素、市场规模的趋势和预测、各个细分市场和地区的细分，总结了竞争环境，主要公司简介等

目录

第 1 章执行摘要

第二章市场概述

第三章研究方法

第 4 章市场动态

  • 摘要
  • 促进因素
  • 抑制因素
  • 机会

第五章市场影响因素分析

  • 价值链分析
  • 波特的五力模型
  • 新冠肺炎 (COVID-19) 的影响

第 6 章全球动物疼痛管理市场：依产品

  • 摘要
  • 药品
    • 非类固醇类抗发炎药 (NSAIDS)
    • 阿片类药物
    • 局部麻醉剂
    • 其他
  • 设备
    • 雷射治疗仪
    • TENS 单位

第 7 章全球动物疼痛管理市场：依应用分类

  • 摘要
  • 关节痛
  • 术后疼痛
  • 癌症疼痛
  • 其他

第 8 章全球兽医疼痛管理市场：依动物类型

  • 摘要
  • 伴侣动物
    • 狗
    • 猫
    • 马
    • 其他
  • 牲畜
    • 牛
    • 猪
    • 家禽
    • 其他

第 9 章全球动物疼痛管理市场：依通路划分

  • 摘要
  • 动物医院/诊所
  • 药房
  • 网路药局

第 10 章按地区划分的全球动物疼痛管理市场

  • 摘要
  • 北美
  • 欧洲
  • 亚太地区
  • 中东/非洲
  • 南美洲

第十一章竞争态势

  • 竞争基准测试
  • 主要成长策略
  • 开发数量领先
  • 主要进展分析
  • 主要发展/成长策略
  • 财务矩阵

第十二章公司简介

  • BOEHRINGER INGELHEIM
  • VETOQUINOL
  • CEVA ANIMAL HEALTH, LLC
  • CHANELLE PHARMA
  • ELANCO
  • DECHRA PHARMACEUTICALS PLC
  • ZOETIS
  • MERCK & CO., INC
  • ASSISI ANIMAL HEALTH
  • ELTECH K-LASER

第13章附录

Product Code: MRFR/MED/4505-CR

Market Overview

Global Veterinary Pain Management market is projected to register a healthy CAGR of 6.44% during the reviewt period. Developing commonness of painful and fiery illnesses in creatures and ascend in sidekick creature proprietorship and huge pet populace are driving market development.

The ascent in sidekick creature possession and enormous animals' populace, ascend in pet protection with a flood in creature wellbeing consumption, and developing predominance of creature illnesses are supposed to drive the development of the worldwide veterinary pain management market.

The rising number of pet people across the globe is supposed to help market development over the forecast period. For example, as per the American Culture for the Anticipation of Mercilessness to Creatures (ASPCA), around 6.5 million sidekick creatures enter the US creature shields cross country every year. Besides, as expressed by the American Pet Items Affiliation 2015 to 2016 (APPA) study, roughly 44% of all families in the US had a canine, and 35% had a feline.

Market Segmentation

Devices and drugs are included in the product-based segmentation of the worldwide veterinary pain treatment market. The market has been further divided into categories based on pharmaceuticals, including opioids, local anesthetics, nonsteroidal anti-inflammatory drugs (NSAIDs), and others. The NSAIDs category has been further divided into categories such as etodolac, meloxicam, and others.

Joint pain, postoperative pain, cancer, and other conditions are among the applications used to segment the worldwide veterinary pain management market.

Companion and farm animals are the two animal types used to segment the worldwide veterinarian pain management market. Dogs, cats, horses, and other animals have been further subdivided under companion animals. The market has been further subdivided into cattle, pigs, poultry, and other livestock-based animals.

The global veterinary pain management market segmentation is based on a distribution channel that includes veterinary hospitals & clinics, pharmacies, and online pharmacies.

Regional Insights

The North America clear aligners market represented the biggest market share in 2022. This is because of the rising pet populace and the rising number of neurological sicknesses in the region. Besides, the presence of numerous observable players like Zoetis (New Jersey, US), Merck and Co., Inc. (New Jersey, US), and Assisi Creature Wellbeing (New Mexico, US) in this region is the significant driving variable of the market in the North America.

Europe Veterinary Pain Management market represents the second-largest market owing to the rising pervasiveness of contagious creature sicknesses and expanded center around the wellbeing and prosperity of creatures is driving the interest in pain management items.

The Asia-Pacific Veterinary Pain Management market expansion is attributed to the presence of quickly creating economies of China, India, and South Korea. The region gives numerous valuable chances to market players to develop. The expanded pet selections and development in the number of inhabitants in sidekick creatures is supposed to drive the market development.

The Middle East and Africa region has less monetary turns of events and very low pay because of which the region represents the least market share yet is supposed to develop with the to further developing veterinary medical care offices and extension of the working-class populace in these regions.

Major Players

Companies such as Boehringer Ingelheim (Ingelheim am Rhein, Germany), Vetoquinol (Lure, France), Ceva Animal Health, LLC (Libourne, France), Dechra Pharmaceuticals PLC (Northwich, UK), Zoetis (New Jersey, US), Merck & Co., Inc. (New Jersey, US), Assisi Animal Health(New Mexico, US), Eltech K-Laser (Treviso, Italy), Chanelle Pharma (Galway, Ireland), and Elanco (Indiana, US).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE
  • 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 GROWING PREVALENCE OF PAINFUL AND INFLAMMATORY DISEASES IN ANIMALS
    • 4.2.2 RISE IN COMPANION ANIMAL OWNERSHIP & LARGE PET POPULATION
    • 4.2.3 RISE IN PET INSURANCE WITH GROWING ANIMAL HEALTH EXPENDITURE
  • 4.3 RESTRAINTS
    • 4.3.1 LACK OF AWARENESS REGARDING ANIMAL HEALTH
    • 4.3.2 UNAFFORDABILITY OF VETERINARY SERVICES IN UNDERDEVELOPED AND DEVELOPING REGIONS
  • 4.4 OPPORTUNITIES
    • 4.4.1 RISING INITIATIVES BY THE GOVERNMENT AND OTHER ORGANIZATIONS

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D & DESIGNING
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION & SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE VETERINARY PAIN MANAGEMENT MARKET
    • 5.3.1 IMPACT SUPPLY CHAIN DISRUPTIONS
    • 5.3.2 IMPACT ON VETERINARY VISITS AND PROCEDURES
    • 5.3.1 IMPACT ON ADAPTATION TO NEW PRACTICES AND TECHNOLOGIES

6 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 MEDICATION
    • 6.2.1 NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)
      • 6.2.1.1.1 MELOXICAM
      • 6.2.1.2 ETODOLAC
      • 6.2.1.3 OTHERS
    • 6.2.2 OPIOIDS
    • 6.2.3 LOCAL ANESTHETICS
    • 6.2.4 OTHERS
  • 6.3 DEVICES
    • 6.3.1 LASER THERAPY DEVICES
    • 6.3.2 TENS UNITS

7 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 JOINT PAIN
  • 7.3 POSTOPERATIVE PAIN
  • 7.4 CANCER
  • 7.5 OTHERS

8 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY ANIMAL TYPE

  • 8.1 OVERVIEW
  • 8.2 COMPANION ANIMALS
    • 8.2.1 DOGS
    • 8.2.2 CATS
    • 8.2.3 HORSES
    • 8.2.4 OTHERS
  • 8.3 LIVESTOCK ANIMALS
    • 8.3.1 CATTLE
    • 8.3.2 PIGS
    • 8.3.3 POULTRY
    • 8.3.4 OTHERS

9 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY DISTRIBUTION CHANNEL

  • 9.1 OVERVIEW
  • 9.2 VETERINARY HOSPITALS & CLINICS
  • 9.3 PHARMACIES
  • 9.4 ONLINE PHARMACIES

10 GLOBAL VETERINARY PAIN MANAGEMENT MARKET, BY REGION

  • 10.1 OVERVIEW
  • 10.2 NORTH AMERICA
    • 10.2.1 US
    • 10.2.2 CANADA
  • 10.3 EUROPE
    • 10.3.1 GERMANY
    • 10.3.2 UK
    • 10.3.3 FRANCE
    • 10.3.4 ITALY
    • 10.3.5 SPAIN
    • 10.3.6 REST OF EUROPE
  • 10.4 ASIA-PACIFIC
    • 10.4.1 CHINA
    • 10.4.2 JAPAN
    • 10.4.3 INDIA
    • 10.4.4 SOUTH KOREA
    • 10.4.5 AUSTRALIA
    • 10.4.6 REST OF ASIA-PACIFIC
  • 10.5 REST OF THE WORLD
    • 10.5.1 LATIN AMERICA
    • 10.5.2 MIDDLE EAST
    • 10.5.3 AFRICA
  • 11.1 OVERVIEW
  • 11.2 COMPETITIVE BENCHMARKING
  • 11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL VETERINARY PAIN MANAGEMENT MARKET
  • 11.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL VETERINARY PAIN MANAGEMENT MARKET
  • 11.5 KEY DEVELOPMENT ANALYSIS
  • 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 11.6.1 PRODUCT APPROVAL AND LAUNCH
    • 11.6.2 EXPANSION
    • 11.6.3 ACQUISITION
  • 11.7 FINANCIAL MATRIX
    • 11.7.1 SALES (USD MILLION), 2022
    • 11.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022

12 COMPANY PROFILES

  • 12.1 BOEHRINGER INGELHEIM
    • 12.1.1 COMPANY OVERVIEW
    • 12.1.2 FINANCIAL OVERVIEW
    • 12.1.3 PRODUCTS OFFERED
    • 12.1.4 KEY DEVELOPMENTS
    • 12.1.5 SWOT ANALYSIS
    • 12.1.6 KEY STRATEGIES
  • 12.2 VETOQUINOL
    • 12.2.1 COMPANY OVERVIEW
    • 12.2.2 FINANCIAL OVERVIEW
    • 12.2.3 PRODUCTS OFFERED
    • 12.2.4 KEY DEVELOPMENTS
    • 12.2.5 SWOT ANALYSIS
    • 12.2.6 KEY STRATEGIES
  • 12.3 CEVA ANIMAL HEALTH, LLC
    • 12.3.1 COMPANY OVERVIEWS
    • 12.3.2 FINANCIAL OVERVIEW
    • 12.3.3 PRODUCTS OFFERED
    • 12.3.4 KEY DEVELOPMENTS
    • 12.3.5 KEY STRATEGIES
  • 12.4 CHANELLE PHARMA
    • 12.4.1 COMPANY OVERVIEW
    • 12.4.2 FINANCIAL OVERVIEW
    • 12.4.3 PRODUCTS OFFERED
    • 12.4.4 KEY DEVELOPMENTS
    • 12.4.5 KEY STRATEGIES
  • 12.5 ELANCO
    • 12.5.1 COMPANY OVERVIEW
    • 12.5.2 FINANCIAL OVERVIEW
    • 12.5.3 PRODUCTS OFFERED
    • 12.5.4 KEY DEVELOPMENTS
    • 12.5.5 SWOT ANALYSIS
    • 12.5.6 KEY STRATEGIES
  • 12.6 DECHRA PHARMACEUTICALS PLC
    • 12.6.1 COMPANY OVERVIEWS
    • 12.6.2 FINANCIAL OVERVIEW
    • 12.6.3 PRODUCTS OFFERED
    • 12.6.4 KEY DEVELOPMENTS
    • 12.6.5 KEY STRATEGIES
  • 12.7 ZOETIS
    • 12.7.1 COMPANY OVERVIEW
    • 12.7.2 FINANCIAL OVERVIEW
    • 12.7.3 PRODUCTS OFFERED
    • 12.7.4 KEY DEVELOPMENTS
    • 12.7.5 SWOT ANALYSIS
    • 12.7.6 KEY STRATEGIES
  • 12.8 MERCK & CO., INC
    • 12.8.1 COMPANY OVERVIEW
    • 12.8.2 FINANCIAL OVERVIEW
    • 12.8.3 PRODUCTS OFFERED
    • 12.8.4 KEY DEVELOPMENTS
    • 12.8.5 SWOT ANALYSIS
    • 12.8.6 KEY STRATEGIES
  • 12.9 ASSISI ANIMAL HEALTH
    • 12.9.1 COMPANY OVERVIEW
    • 12.9.2 FINANCIAL OVERVIEW
    • 12.9.3 PRODUCTS OFFERED
    • 12.9.4 KEY DEVELOPMENTS
    • 12.9.5 KEY STRATEGIES
  • 12.10 ELTECH K-LASER
    • 12.10.1 COMPANY OVERVIEW
    • 12.10.2 FINANCIAL OVERVIEW
    • 12.10.3 PRODUCTS OFFERED
    • 12.10.4 KEY DEVELOPMENTS
    • 12.10.5 KEY STRATEGIES

13 APPENDIX

  • 13.1 REFERENCES
  • 13.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 4 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR MEDICATION, BY REGION 2019-2030 (USD MILLION)
  • TABLE 5 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR MEDICATION, BY TYPE 2019-2030 (USD MILLION)
  • TABLE 6 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION 2019-2030 (USD MILLION)
  • TABLE 7 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE 2019-2030 (USD MILLION)
  • TABLE 8 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR MELOXICAM, BY REGION 2019-2030 (USD MILLION)
  • TABLE 9 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR ETODOLAC, BY REGION 2019-2030 (USD MILLION)
  • TABLE 10 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR OTHERS, BY REGION 2019-2030 (USD MILLION)
  • TABLE 11 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR OPIOIDS, BY REGION 2019-2030 (USD MILLION)
  • TABLE 12 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR LOCAL ANESTHETICS, BY REGION 2019-2030 (USD MILLION)
  • TABLE 13 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR OTHERS, BY REGION 2019-2030 (USD MILLION)
  • TABLE 14 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR DEVICES, BY REGION 2019-2030 (USD MILLION)
  • TABLE 15 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 16 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR JOINT PAIN, BY REGION 2019-2030 (USD MILLION)
  • TABLE 17 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR POSTOPERATIVE PAIN, BY REGION 2019-2030 (USD MILLION)
  • TABLE 18 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR CANCER, BY REGION 2019-2030 (USD MILLION)
  • TABLE 19 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR OTHERS, BY REGION 2019-2030 (USD MILLION)
  • TABLE 20 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 21 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR COMPANION ANIMALS, BY REGION 2019-2030 (USD MILLION)
  • TABLE 22 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 23 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR DOGS, BY REGION 2019-2030 (USD MILLION)
  • TABLE 24 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR CATS, BY REGION 2019-2030 (USD MILLION)
  • TABLE 25 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR HORSES, BY REGION 2019-2030 (USD MILLION)
  • TABLE 26 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR OTHERS, BY REGION 2019-2030 (USD MILLION)
  • TABLE 27 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR LIVESTOCK ANIMALS, BY REGION 2019-2030 (USD MILLION)
  • TABLE 28 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 29 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR CATTLE, BY REGION 2019-2030 (USD MILLION)
  • TABLE 30 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR PIGS, BY REGION 2019-2030 (USD MILLION)
  • TABLE 31 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR POULTRY, BY REGION 2019-2030 (USD MILLION)
  • TABLE 32 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR OTHERS, BY REGION 2019-2030 (USD MILLION)
  • TABLE 33 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 34 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR VETERINARY HOSPITALS AND CLINICS, BY REGION 2019-2030 (USD MILLION)
  • TABLE 35 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR PHARMACIES, BY REGION 2019-2030 (USD MILLION)
  • TABLE 36 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR ONLINE PHARMACIES, BY REGION 2019-2030 (USD MILLION)
  • TABLE 37 GLOBAL: VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 38 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 39 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 40 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 41 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 42 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 43 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 44 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 45 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 46 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 47 US: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 48 US: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 49 US: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 50 US: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 51 US: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 52 US: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 53 US: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 54 US: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 55 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 56 CANADA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 57 CANADA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 58 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 59 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 60 CANADA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 61 CANADA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 62 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 63 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 64 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 65 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 66 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 67 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 68 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 69 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 70 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 71 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 72 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 73 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 74 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 75 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 76 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 77 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 78 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 79 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 80 UK: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 81 UK: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 82 UK: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 83 UK: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 84 UK: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 85 UK: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 86 UK: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 87 UK: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 88 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 89 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 90 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 91 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 92 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 93 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 94 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 95 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 96 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 97 ITALY: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 98 ITALY: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 99 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 100 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 101 ITALY: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 102 ITALY: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 103 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 104 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 105 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 106 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 107 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 108 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 109 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 110 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 111 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 112 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 113 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 114 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 115 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 116 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 117 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 118 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 119 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 120 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 121 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 122 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 123 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 124 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 125 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 126 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 127 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 128 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 129 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 130 CHINA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 131 CHINA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 132 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 133 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 134 CHINA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 135 CHINA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 136 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 137 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 138 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 139 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 140 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 141 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 142 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 143 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 144 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 145 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 146 INDIA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 147 INDIA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 148 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 149 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 150 INDIA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 151 INDIA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 152 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 153 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 154 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 155 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 156 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 157 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 158 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 159 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 160 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 161 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 162 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 163 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 164 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 165 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 166 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 167 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 168 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 169 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 170 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 171 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 172 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 173 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 174 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 175 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 176 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 177 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 178 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 179 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 180 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 181 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 182 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 183 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 184 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 185 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 186 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 187 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 188 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 189 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 190 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 191 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 192 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 193 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 194 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 195 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 196 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 197 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 198 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 199 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 200 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 201 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 202 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 203 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 204 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 205 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 206 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)
  • TABLE 207 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 208 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 209 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)
  • TABLE 1 MAJOR PLAYERS IN THE GLOBAL VETERINARY PAIN MANAGEMENT MARKET
  • TABLE 2 BENCHMARKING OF MAJOR COMPETITORS
  • TABLE 3 MOST ACTIVE PLAYER IN THE GLOBAL VETERINARY PAIN MANAGEMENT MARKET
  • TABLE 4 PRODUCT APPROVAL AND LAUNCH: GLOBAL VETERINARY PAIN MANAGEMENT MARKET
  • TABLE 5 EXPANSION: GLOBAL VETERINARY PAIN MANAGEMENT MARKET
  • TABLE 6 ACQUISITION: GLOBAL VETERINARY PAIN MANAGEMENT MARKET
  • TABLE 7 BOEHRINGER INGELHEIM: PRODUCTS OFFERED
  • TABLE 8 BOEHRINGER INGELHEIM: KEY DEVELOPMENTS
  • TABLE 9 VETOQUINOL: PRODUCTS OFFERED
  • TABLE 10 CEVA ANIMAL HEALTH, LLC: PRODUCTS OFFERED
  • TABLE 11 CEVA ANIMAL HEALTH, LLC: KEY DEVELOPMENTS
  • TABLE 12 CHANELLE PHARMA: PRODUCTS OFFERED
  • TABLE 13 CHANELLE PHARMA: KEY DEVELOPMENTS
  • TABLE 14 ELANCO: PRODUCTS OFFERED
  • TABLE 15 ELANCO: KEY DEVELOPMENTS
  • TABLE 16 DECHRA PHARMACEUTICALS PLC: PRODUCTS OFFERED
  • TABLE 17 ZOETIS: PRODUCTS OFFERED
  • TABLE 18 ZOETIS: KEY DEVELOPMENTS
  • TABLE 19 MERCK & CO., INC: PRODUCTS OFFERED
  • TABLE 20 ASSISI ANIMAL HEALTH: PRODUCTS OFFERED
  • TABLE 21 ELTECH K-LASER: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL VETERINARY PAIN MANAGEMENT MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL VETERINARY PAIN MANAGEMENT MARKET
  • FIGURE 5 DRIVER IMPACT ANALYSIS
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS: VETERINARY PAIN MANAGEMENT MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: VETERINARY PAIN MANAGEMENTMARKET
  • FIGURE 9 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, PRODUCT TYPE SEGMENT ATTRACTIVENESS, 2022 & 2030 (USD MILLION)
  • FIGURE 10 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY PRODUCT, 2022 & 2030 (USD MILLION)
  • FIGURE 11 GLOBAL VETERINARY PAIN MANAGAMENT MARKET SHARE, BY PRODUCT, 2022 (%)
  • FIGURE 12 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022 & 2030 (USD MILLION)
  • FIGURE 13 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY APPLICATION, 2022 & 2030 (USD MILLION)
  • FIGURE 14 GLOBAL VETERINARY PAIN MANAGAMENT MARKET SHARE, BY APPLICATION, 2022 (%)
  • FIGURE 15 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, METHOD SEGMENT ATTRACTIVENESS, 2022 & 2030 (USD MILLION)
  • FIGURE 16 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY ANIMAL TYPE, 2022 & 2030 (USD MILLION)
  • FIGURE 17 GLOBAL VETERINARY PAIN MANAGAMENT MARKET SHARE, BY ANIMAL TYPE, 2022 (%)
  • FIGURE 18 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, DISTRIBUTION CHANNEL SEGMENT ATTRACTIVENESS, 2023-2030 (USD MILLION)
  • FIGURE 19 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2030 (USD MILLION)
  • FIGURE 20 GLOBAL VETERINARY PAIN MANAGAMENT MARKET SHARE, BY DISTRIBUTION CHANNEL, 2022 (%)
  • FIGURE 21 GLOBAL: VETERINARY PAIN MANAGEMENT MARKET, BY REGION 2022 & 2030 (USD MILLION)
  • FIGURE 22 GLOBAL: VETERINARY PAIN MANAGEMENT MARKET SHARE (%), BY REGION, 2022
  • FIGURE 23 NORTH AMERICA MARKET ANALYSIS: VETERINARY PAIN MANAGEMENT MARKET, 2019-2030 (USD MILLION)
  • FIGURE 24 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
  • FIGURE 25 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 26 EUROPE MARKET ANALYSIS: VETERINARY PAIN MANAGEMENT MARKET, 2019-2030 (USD MILLION)
  • FIGURE 27 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
  • FIGURE 28 EUROPE: VETERINARY PAIN MANAGEMENT MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 29 ASIA-PACIFIC MARKET ANALYSIS: VETERINARY PAIN MANAGEMENT MARKET, 2019-2030 (USD MILLION)
  • FIGURE 30 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
  • FIGURE 31 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 32 REST OF THE WORLD MARKET ANALYSIS: VETERINARY PAIN MANAGEMENT MARKET, 2019-2030 (USD MILLION)
  • FIGURE 33 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
  • FIGURE 34 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 35 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL VETERINARY PAIN MANAGEMENT MARKET
  • FIGURE 36 GLOBAL VETERINARY PAIN MANAGEMENT MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 37 SALES 2022
  • FIGURE 38 RESEARCH & DEVELOPMENT EXPENDITURE, 2022
  • FIGURE 39 BOEHRINGER INGELHEIM: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 40 BOEHRINGER INGELHEIM: SWOT ANALYSIS
  • FIGURE 41 VETOQUINOL: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 42 VETOQUINOL: SWOT ANALYSIS
  • FIGURE 43 ELANCO: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 44 ELANCO: SWOT ANALYSIS
  • FIGURE 45 DECHRA PHARMACEUTICALS PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 46 ZOETIS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 47 ZOETIS: SWOT ANALYSIS
  • FIGURE 48 MERCK & CO., INC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 49 MERCK & CO., INC: SWOT ANALYSIS